Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
Market Closed
12 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
14. 59
+0.68
+4.8886%
$
1.21B Market Cap
- P/E Ratio
- Div Yield
1.69M Volume
- Eps
$ 13.91
Previous Close 
Want to track AMLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) Statistics
Valuation metrics
Market Cap 1.21B
Enterprise value 989.29M
Trailing P/E (ttm) -10.75
Forward P/E -
PEG ratio -0.13
Price/Sales (ttm) -
Price/Book (mrq) 5.91
Enterprise Value/Revenue -
Enterprise Value/EBITDA -6.58
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.33M
Average volume (90 days) 1.13M
Price summary
52-Week low 4.8
52-Week high 18.61
Beta -
50-Day moving average 14.96
200-Day moving average 14.39
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.51%
Return on equity -0.56%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.53
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 17.85%
Book value per share (mrq) 2.47
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
